Drugs / BOR15001L7
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03977792 | Sep 2020 → Jul 2021 | herpes labialis | Laboratoire Boreaderme Inc. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BOR15001L7 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03977792 ↗ |
| Modality | Other / unclassified | “BOR15001L7 is a natural product.” NCT03977792 ↗ |
| Route | Topical | “BOR15001L7 topically applied to infected area” NCT03977792 ↗ |